Search results
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
GuruFocus.com via Yahoo Finance· 6 hours agoRevenue: Q1 2024 revenue was $2.2 million, up from $0.7 million in Q1 2023. Cash, Cash Equivalents, and Investments: Ended Q1 2024 with $36.7 million. BARDA Funding: Received ...
University Lab Partners Selected to Lead the Next Generation of the BARDA Accelerator Network as the...
Coronado Eagle & Journal· 7 days agoUniversity Lab Partners (ULP), a premier nonprofit wet lab incubator located in Orange County, CA, has been chosen to lead the diagnostics and medical devices hub in the next generation of the ...
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
GuruFocus.com via Yahoo Finance· 6 days ago:OPK) has several promising pharmaceutical programs set to enter clinical trials, including a multi-specific oncology antibody and a vaccine licensed to Merck. The company has secured non-dilutive ...
BARDA announces first next-generation countermeasure accelerator hubs
Center for Infectious Disease Research and Policy· 7 days agoOne hub focuses on diagnostics and medical devices, and the other targets therapeutics and vaccines.
Spectral AI hails progress towards first sales and pre-FDA clinical trial
Proactive Investors· 6 days agoAt the end of March, cash stood at $10.2 million, up from $4.8 million at the end of December, which...
EverGlade Consulting Welcomes New Managing Director, Joe Larsen
Tri-County Times· 2 weeks agoEverGlade Consulting is pleased to announce the appointment of Dr. Joe Larsen as Managing Director, effective April 2024. Dr. Larsen brings with him a rich background in biomedical research ...
Spectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoSpectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript May 11, 2024 Spectral AI, Inc....
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 14 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Magazine: Anticipation rises for RSV rollout as positive data emerges
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoIn this issue: Following the RSV therapy and vaccine rollout, understanding molecular glues, using...
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 weeks agoWe also strengthened our relationship with key stakeholders during the quarter. Over the last three...